{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:45:37Z","timestamp":1788864337412,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000098","name":"National Institutes of Health Clinical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bone.2021.115977","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T07:05:39Z","timestamp":1619593539000},"page":"115977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Therapy with PTH 1\u201334 or calcitriol and calcium in diverse etiologies of hypoparathyroidism over 27\u00a0years at a single tertiary care center"],"prefix":"10.1016","volume":"149","author":[{"given":"Karen K.","family":"Winer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangyuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise M.N.","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Gordon B.","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail S.","family":"Lionakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2021.115977_bb0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bone.2018.09.018","article-title":"Advances in the treatment of Hypoparathyroidism with PTH 1-34","volume":"120","author":"Winer","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.115977_bb0010","doi-asserted-by":"crossref","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","article-title":"Hypoparathyroidism","volume":"3","author":"Mannstadt","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"13","key":"10.1016\/j.bone.2021.115977_bb0015","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88782","article-title":"Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"1","author":"Ferre","year":"2016","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.bone.2021.115977_bb0020","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/jc.2016-1821","article-title":"Longitudinal follow-up of autoimmune polyendocrine syndrome type 1","volume":"101","author":"Bruserud","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2021.115977_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/imr.12714","article-title":"Lessons from primary immunodeficiencies: autoimmune regulator and autoimmune polyendocrinolopathy-candidiasis-ectodermal dystrophy","volume":"287","author":"Constantine","year":"2019","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.bone.2021.115977_bb0030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/hmg\/5.5.601","article-title":"Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism","volume":"5","author":"Baron","year":"1996","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bone.2021.115977_bb0035","doi-asserted-by":"crossref","first-page":"F485","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bone.2021.115977_bb0040","doi-asserted-by":"crossref","unstructured":"Winer KK Yanovski JA, and Cutler, G.B., Jr. Synthetic human parathyroid hormone 1\u201334 versus calcitriol in the treatment of hypoparathyroidism: results of a short-term randomized trial JAMA 1996 276 631\u20136.","DOI":"10.1001\/jama.1996.03540080053029"},{"key":"10.1016\/j.bone.2021.115977_bb0045","article-title":"A randomized, crossover trial of once-daily versus twice-daily human parathyroid hormone 1-34 in the treatment of hypoparathyroidsim","volume":"83","author":"Winer","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.bone.2021.115977_bb0050","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.bone.2021.115977_bb0055","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-2552","article-title":"Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism","volume":"93","author":"Winer","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bone.2021.115977_bb0060","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2021.115977_bb0065","first-page":"391","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bone.2021.115977_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2014.04.060","article-title":"Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1\u201334 in children with severe congenital hypoparathyroidism","volume":"165","author":"Winer","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bone.2021.115977_bb0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jpeds.2018.08.010","article-title":"Long-term parathyroid hormone 1\u201334 replacement therapy in children with hypoparathyroidism","volume":"203","author":"Winer","year":"2018","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.bone.2021.115977_bb0080","first-page":"183","article-title":"Studies on the physiology of the parathyroid glands; calcium and phosphorus studies on a case of idiopathic hypoparathyroidism","volume":"7","author":"Albirght","year":"1929","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2021.115977_bb0085","first-page":"141","article-title":"First experiences in the substitution treatment of hypoparathyroidism with synthetic human parathyroid hormone","volume":"138","author":"Strogmann","year":"1990","journal-title":"Monatasschr Kinderheilkd"},{"key":"10.1016\/j.bone.2021.115977_bb0090","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1210\/jc.2011-1359","article-title":"Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism","volume":"96","author":"Linglart","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2021.115977_bb0095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000479867","article-title":"Continuous subcutaneous recombinant parathyroid hormone (1-34) infusion in the Management of Childhood Hypoparathyroidism Associated with Malabsorption","volume":"89","author":"Saraff","year":"2018","journal-title":"Horm. Res. Paediatr."},{"issue":"5","key":"10.1016\/j.bone.2021.115977_bb0100","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00198-012-2230-4","article-title":"PTH replacement therapy of hypoparathyroidism","volume":"24","author":"Rejnmark","year":"2013","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bone.2021.115977_bb0105","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2021.115977_bb0110","first-page":"47","article-title":"Perspectives on the search for a true physiologic replacement therapy for hypoparathyroidism","volume":"12","author":"Winer","year":"2016","journal-title":"Eur. Endocrinol."},{"issue":"7","key":"10.1016\/j.bone.2021.115977_bb0115","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1210\/jc.2017-02593","article-title":"Replacement therapy improve quality of life in patients with chronic hypoparathyroidism?","volume":"103","author":"Winer","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2021.115977_bb0120","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/jbmr.2812","article-title":"Concurrent hypoparathyroidism is associated with impaired physical function and quality of life in hypothyroidism","volume":"31","author":"Sikjaer","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2021.115977_bb0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1460215","article-title":"Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D","volume":"146","author":"Arlt","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bone.2021.115977_bb0130","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1210\/jc.2013-1239","article-title":"The effect of PTH 1-84 on quality of life in hypoparathyroidism","volume":"98","author":"Cusano","year":"2013","journal-title":"JCEM"},{"issue":"1\u20132","key":"10.1016\/j.bone.2021.115977_bb0135","first-page":"53","article-title":"Teriparatide (rhPTH) treatment in children with syndromic hypoparathyroidism","volume":"27","author":"Matarazzo","year":"2014","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.bone.2021.115977_bb0140","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bone.2021.115977_bb0145","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bone.2021.115977_bb0150","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical Hypoparathyroidism in Denmark: a Nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2021.115977_bb0155","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.0006-341X.2005.464_1.x","article-title":"On analyzing circadian rhythms data using nonlinear mixed models with harmonic terms","volume":"61","author":"Albert","year":"2005","journal-title":"Biometrics."},{"issue":"6","key":"10.1016\/j.bone.2021.115977_bb0160","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/cen.12944","article-title":"Diverse genetic aetiologies and clinical outcomes of paediatric hypoparathyroidism","volume":"83","author":"Kim","year":"2015","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2021.115977_bb0165","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/wdev.75","article-title":"The 22q11 deletion: DiGeorge and velocardiofacial syndromes and the role of TBX1","volume":"2","author":"Papangeli","year":"2013","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"issue":"11","key":"10.1016\/j.bone.2021.115977_bb0170","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1210\/jc.2018-01260","article-title":"Heterozygous mutations in TBX1 as a cause of isolated hypoparathyroidism","volume":"103","author":"Li","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"26","key":"10.1016\/j.bone.2021.115977_bb0175","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit \u03b111 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bone.2021.115977_bb0180","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1210\/jc.2019-00893","article-title":"Therapy of hypoparathyroidism with rhPTH(1\u201384): a prospective, 8-year investigation of efficacy and safety","volume":"104","author":"Tay","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bone.2021.115977_bb0185","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1210\/jc.2015-3910","article-title":"Management of hypoparathyroidism: present and future","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bone.2021.115977_bb0190","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","article-title":"KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD)","volume":"55","author":"Uhlig","year":"2010","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"10.1016\/j.bone.2021.115977_bb0195","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.ki.5002412","article-title":"The fallacy of the calcium-phosphorus product","volume":"72","author":"O\u2019Neill","year":"2007","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.bone.2021.115977_bb0200","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-18-0609","article-title":"Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus","volume":"180","author":"Khan","year":"2019","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2021.115977_bb0205","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2265.2012.04353.x","article-title":"Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism","volume":"77","author":"Goswami","year":"2012","journal-title":"Clin. Endocrinol."},{"issue":"11","key":"10.1016\/j.bone.2021.115977_bb0210","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM197803162981101","article-title":"Treatment of hypoparathyroid patients with chlorthalidone","volume":"298","author":"Porter","year":"1978","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bone.2021.115977_bb0215","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/pds.4636","article-title":"Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population","volume":"27","author":"Kieboom","year":"2018","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.bone.2021.115977_bb0220","article-title":"Impact of peri-procedural subcutaneous parathyroid hormone on control of hypocalcemia in APS-1\/APECED patients undergoing invasive procedures","author":"Winer","year":"2020","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.bone.2021.115977_bb0225","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1\u201384) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bone.2021.115977_bb0230","unstructured":"Chascsa DM, Ferr\u00e9 EMN, Hadjiyannis Y, et al. APECED-associated hepatitis: clinical, biochemical, histological and treatment data from a large predominantly American Cohort [published online ahead of print, 2020 Jun 17]. Hepatology. 2020;10.1002."},{"issue":"495","key":"10.1016\/j.bone.2021.115977_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5597","article-title":"Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance","volume":"11","author":"Ferr\u00e9","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.bone.2021.115977_bb0240","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/jbmr.3824","article-title":"Design and preclinical development of TransCon PTH, an investigational sustained-release PTH replacement therapy for hypoparathyroidism","volume":"34","author":"Holten-Andersen","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2021.115977_bb0245","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/jbmr.2811","article-title":"Pharmacodynamic actions of a long-acting PTH analog (LA-PTH) in thyroparathyroidectomized (TPTX) rats and normal monkeys","volume":"31","author":"Shimizu","year":"2016","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221001393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221001393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:42:50Z","timestamp":1762659770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":49,"alternative-id":["S8756328221001393"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.115977","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapy with PTH 1\u201334 or calcitriol and calcium in diverse etiologies of hypoparathyroidism over 27\u00a0years at a single tertiary care center","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.115977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115977"}}